LMNA-NTRK1 fusion
|
Breast Cancer
|
LMNA-NTRK1 fusion
|
Breast Cancer
|
larotrectinib Sensitive: C3 – Early Trials
|
larotrectinib Sensitive: C3 – Early Trials
|
LMNA-NTRK1 fusion
|
Soft Tissue Sarcoma
|
LMNA-NTRK1 fusion
|
Soft Tissue Sarcoma
|
larotrectinib Sensitive: C4 – Case Studies
|
larotrectinib Sensitive: C4 – Case Studies
|
LMNA-NTRK1 fusion
|
Breast Cancer
|
LMNA-NTRK1 fusion
|
Breast Cancer
|
ceritinib Sensitive: D – Preclinical
|
ceritinib Sensitive: D – Preclinical
|